Renato Skerlj is the founder of Expansion Therapeutics. Expansion Therapeutics has raised $135M in total funding. Latest round: Series B. Based in Boston, MA.
Renato Skerlj, Ph.D., is the Chief Executive Officer and President of Expansion Therapeutics, a biotechnology company focused on developing RNA-modulating drugs for neurodegenerative diseases. He has led the company through significant funding rounds, including an $80 million Series B and a $55.3 million Series A.
Full founder directory · Investor directory · Company funding database · Fundraising library